Barry J Cusack - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Barry J Cusack

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Biochemical and Biophysical Research Communications|February 22, 2002

Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expressionHerve A Gambliel, Briant E Burke, Barry J Cusack, et al.

Molecular Pharmacology|February 12, 2005

Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazineHenry A Charlier, Richard D Olson, Carissa M Thornock, et al.

Cardiovascular Toxicology|December 31, 2005

Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductaseAndrew Slupe, Berea Williams, Corianton Larson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Biochemical and Biophysical Research Communications|February 22, 2002

Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expressionHerve A Gambliel, Briant E Burke, Barry J Cusack, et al.

Molecular Pharmacology|February 12, 2005

Cardiovascular Toxicology|December 31, 2005

Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductaseAndrew Slupe, Berea Williams, Corianton Larson, et al.

Pageof 2